Encompass Health Corporation

NYSE:EHC

Medical - Care Facilities

Healthcare
$134.93 -1.95%

-$1.95 today

Market cap
$13.24B
Beta
0.59
P/E (TTM)
15.9
EPS (TTM)
$6.14
Dividend yield
0.76%
52W Low $92.77High $127.99

Volume 0.84M

Average 0.92M

EHC Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

Encompass Health CorporationNYSE: EHC

Accounts Receivables · Q2 FY2026 · quarter ended Jun 2026

Accounts receivables turns negative

Q2 FY2026 accounts receivables was -$10.2M, compared with $9M a year earlier. Trailing-twelve-month accounts receivables was -$62.9M. Over 3 fiscal years it compounded at -3.5% a year.

Context

  • Accounts receivables amounted to 0.3% of revenue in FY2025, up 0.2 pp from a year earlier.
  • Accounts receivables increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly accounts receivables holds near -$10.2M or moves back toward the trailing-twelve-month quarterly average of -$15.73M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$10.2M-80.8% QoQ
Last fiscal yearDec 2025
-$15.2M-606.7% YoY
LTMJun 2026
-$62.9M+362.5% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-213.3%——
1 year-606.7%——
3-year CAGR-3.5%——
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
(15.2M) USD
Year-over-year change
-606.7%

Accounts Receivables vs competitors

How EHC compares with its peers on the latest reported figures

  • EHC's LTM Jun 2026 accounts receivables of $62.9M is the 2nd largest of the 9 companies compared; the peer median is $10.14M.
  • Its year-over-year change of +362.5% is the 2nd highest of 9, against a peer median of +76.4%.
  • Accounts receivables amounts to 1.0% of revenue for EHC, versus a peer median of 0.6%.
EHC Competitors Peer median
Accounts Receivables for EHC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ENSGThe Ensign Group, Inc.LTM Jun 2026$91.03M +197.4%-5.1%1.7%
EHCEncompass Health CorporationLTM Jun 2026$62.9M +362.5%-3.5%1.0%
OPCHOption Care Health, Inc.LTM Sep 2026$31.17M -13.9%+14.0%0.5%
PACSPACS Group, Inc.LTM Jun 2026$18.69M -68.5%—0.3%
AVAHAveanna Healthcare Holdings Inc.LTM Oct 2026$16.53M +166.8%+110.8%0.6%
PNTGThe Pennant Group, Inc.LTM Mar 2026$10.3M -57.9%+305.9%1.0%
ADUSAddus HomeCare CorporationLTM Jun 2026$9.98M -1289.6%—0.7%
NHCNational HealthCare CorporationLTM Sep 2026$8.96M +344.5%-1.6%0.6%
CHEChemed CorporationLTM Jun 2026$4.85M +1224.0%+68.7%0.2%
Peer median (excluding EHC) $10.14M+76.4%+41.3%0.6%

Competitors are the stored peer set for EHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income517.6M365.9M361.6M599.4M567.2M
Depreciation & Amortization219.6M243.6M273.9M299.6M327.9M
Deferred Income Tax17.4M27.9M3.9M10.7M22.3M
Stock-Based Compensation29.1M29.2M50.6M48.3M0
Change in Working Capital(118M)(30.4M)50.3M21.9M4.3M
Accounts Receivables(64.3M)(16.9M)(22.4M)3M(15.2M)
Inventory00000
Accounts Payables14.9M2.3M11.8M3M(22.6M)
Other Working Capital(68.6M)(15.8M)60.9M15.9M42.1M
Other Non-Cash Items50.1M69.6M110.5M22.9M253.9M
Operating Cash Flow715.8M705.8M850.8M1B1.18B
Capital Expenditures(551.2M)(584.1M)(583.1M)(642.5M)(736.4M)
Acquisitions (Net)(118.6M)64.1M000
Purchases of Investments(9M)(35.2M)(23M)(22.5M)(184.4M)
Sales of Investments9M(64.1M)018.9M172.8M
Other Investing Activities3.5M(7.7M)3.3M(7.2M)(14.8M)
Investing Cash Flow(666.3M)(627M)(602.8M)(653.3M)(762.8M)
Debt Repayment(59.1M)(498.2M)(83.3M)(242M)(29M)
Common Stock Issued00000
Common Stock Repurchased(14.6M)(7.3M)(8.2M)(31.1M)(158M)
Dividends Paid(112.2M)(99M)(60.4M)(62.8M)(71.1M)
Other Financing Activities(54.2M)458.8M(45.3M)5.3M(174.9M)
Financing Cash Flow(240.1M)(145.7M)(197.2M)(330.6M)(433M)
Effect of Forex Changes00000
Net Change in Cash(190.6M)(66.9M)50.8M18.9M(20.2M)
Free Cash Flow164.6M121.7M267.7M360.3M439.2M

Encompass Health Corporation

NYSE:EHC

Intrinsic Alpha fair value

Locked

Current Price

$134.93

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.